Cadila Plant In Ahmedabad Shut After 26 Workers Test Positive For Covid-19
The firm has initiated sanitisation of the plant and its surroundings
Topics
Coronavirus | Cadila | Ahmedabad
ANI Last Updated at May 8, 2020 10:46 IST
The firm has initiated sanitisation of the plant and its surroundings
In a worrying situation, manufacturing plant of Cadila Pharmaceuticals in Ahmedabad has been closed after 26 of its employees tested positive for the coronavirus.
The firm has initiated sanitisation of the plant and its surroundings.
"Manufacturing plant of Cadila Pharmaceuticals at Dholka in Ahmedabad, Gujarat has been closed following 26 of its employees testing positive for COVID-19. Deep sanitization of the plant & its surroundings is being undertaken," the statement from Cadila Pharmaceuticals read.
More details in this regard are awaited.
First Published: Thu, May 07 2020. 22:13 IST
PREVIOUS STORY
NEXT STORY
';if(neverShowNotificaitonCookie==''||neverShowNotificaitonCookie=='undefined'||neverShowNotificaitonCookie==null){var lastReminderCookie=getCookie('_ler'+loginParamObj.uId);if((lastReminderCookie=="")||(lastReminderCookie=="undefined")||(lastReminderCookie==null)){$('body').prepend(notificationBox);}else{if(lastReminderCookie
HSBC Swings The Axe At UK Wealth In An AI Push
HSBC is preparing deep job cuts across its UK wealth management arm. It plans to cut about half of its management and sp... Read more
Kraken's Owner Buys A Bank: The Lines Are Blurring
Payward, the parent company of the crypto exchange Kraken, has agreed to buy a European bank. It would be the first digi... Read more
Revoluts Australian Banking Licence Game Changer
Revolut has spent much of its life insisting that it is more than a bank. In Australia, it has now decided that becoming... Read more
The AI Bank Is Coming, But Who Controls The Risk?
Artificial intelligence is no longer something banks discuss as a distant possibility. It is already working behind the ... Read more
ClearBank UK Profit Leads To European Growth
ClearBank has spent much of the past decade building the technology and regulatory infrastructure needed to challenge so... Read more